Page last updated: 2024-11-04

sulfasalazine and Paralysis

sulfasalazine has been researched along with Paralysis in 1 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Paralysis: A general term most often used to describe severe or complete loss of muscle strength due to motor system disease from the level of the cerebral cortex to the muscle fiber. This term may also occasionally refer to a loss of sensory function. (From Adams et al., Principles of Neurology, 6th ed, p45)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Okazaki, T1
Kodama, D1
Yamadera, M1
Sugiyama, Y1
Tsuji, H1
Nishida, F1
Ooka, Y1
Nakamichi, K1
Hashikawa, K1
Yanagihara, T1

Other Studies

1 other study available for sulfasalazine and Paralysis

ArticleYear
[Progressive multifocal leukoencephalopathy in a patient with rheumatoid arthritis under salazosulfapyridine treatment].
    Rinsho shinkeigaku = Clinical neurology, 2021, Dec-22, Volume: 61, Issue:12

    Topics: Activities of Daily Living; Aged, 80 and over; Arthritis, Rheumatoid; Humans; JC Virus; Leukoencepha

2021